- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Development of high-performance frontal analysis and its application to the study of the drug-protein binding sites.
-
- NAKAGAWA Terumichi
- Faculty of Pharmaceutical Sciences, Kyoto University
-
- SHIBUKAWA Akimasa
- Faculty of Pharmaceutical Sciences, Kyoto University
Bibliographic Information
- Other Title
-
- 高速先端分析法の開発と薬物‐タンパク結合研究への応用
- コウソク センタン ブンセキホウ ノ カイハツ ト ヤクブツ タンパク ケツゴ
- 高速先端分析法の開発と薬物-タンパク結合研究への応用
Search this article
Description
High-performance frontal analysis (HPFA) is a novel chromatographic method originally developed for the determination of unbound drug concentration in protein binding equilibrium. The present paper deals with the rationale and features of the HPFA method. HPFA uses a "restricted-access "HPLC column which is designed to size-exclude macromolecules such as plasma proteins, but to retain drugs of small molecular size. When a certain excess volume of drug-protein mixed solution is continuously injected to the column with the mobile phase, the protein binding equilibrium, same as that in the sample solution is reproduced in a limited zone near the top of the column. Consequently, the unbound drug is eluted as a zonal peak, being separated from the protein peak. Therefore, the unbound drug concentration can be determined from the plateau height of the drug peak. When the drug peak is completely separated from the protein peak, the total drug concentration can be also determined from the peak area. This is the rationale of the HPFA method. The HPFA method has several features; (i) it does not suffer from the undesirable adsorption of drug to the filter membrane and the leakage of unbound drug from the membrane, which are often encountered in the widely used equilibrium dialysis method and the ultrafiltration method, (ii) it is easy to incorporate HPFA into on-line HPLC systems, (iii) the unbound drug solution of larger volume than the injected sample volume is obtained when the drug is highly bound to protein. HPFA are applied to the simultaneous determination of total and unbound carbamazepine concentrations in human plasma and stereoselective determinations of unbound warfarin and ketoprofen following direct sample injection.
Journal
-
- BUNSEKI KAGAKU
-
BUNSEKI KAGAKU 40 (5), 203-214, 1991
The Japan Society for Analytical Chemistry
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679028988032
-
- NII Article ID
- 110002906264
-
- NII Book ID
- AN00222633
-
- NDL BIB ID
- 3719072
-
- ISSN
- 05251931
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- NDL Digital Collections (NII-ELS)
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed